Loading...
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) modalities can reduce oedema and thereby improve vision and prevent further visual loss. These drugs have replaced laser photoco...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481463/ https://ncbi.nlm.nih.gov/pubmed/28639415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007419.pub5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|